Co-primary objectives: | |
1. To test if the SDTC changes (at planned first post-dose timing) of large sensory fibers differ in the lacosamide period as compared to the placebo period. | |
2. To test if the SDTC changes (at planned first post-dose timing) of large motor fibers differs in the lacosamide period as compared to the placebo period. | |
Key secondary objectives: | |
1. To test if the SDTC changes (at planned first post-dose timing) of large sensory fibers differ in the pregabalin and/or tapentadol periods as compared to the placebo period. | |
2. To test if the SDTC changes (at planned first post-dose timing) of large motor fibers in the pregabalin and/or tapentadol periods differs as compared to the placebo period. | |
3. To test if the SDTC changes (at planned first post-dose timing) of small sensory fibers differ in the lacosamide period as compared to the placebo period. |